바이오뱅크 시장 - 제품별, 샘플별, 용도별, 스토리지 유형별, 최종사용자별, 세계 예측(2023-2032년)

The biobanking market will grow at a 7.2% CAGR from 2023 to 2032. Increasing focus on personalized medicine, genomics, and drug discovery, necessitating extensive biorepositories for large-scale sample storage and analysis will drive the market ahead.

The growing demand for biomarker identification and disease research, alongside collaborations between biobanks, research institutions, and pharmaceutical companies have increased, fueling business expansion.

The recognition of the importance of preserving biological specimens for future studies and medical advancements will attract investments and drive growth in the biobanking industry. In October 2021, Thermo Fisher Scientific introduced a range of compliant, sustainable blood bank refrigerators tailored for the storage of blood and related samples, for the benefit of healthcare professionals and clinical researchers.

The overall biobanking market is segregated based on product & service, sample type, application, storage type, end-user, and region.

The consumables product & service segment will exhibit a 6.8% CAGR through 2032. This is attributed to the increasing demand for sample collection and storage solutions. The rising need for sample preservation in research, diagnostics, and drug development will augment growth in the segment.

Based on sample type, the human tissues sample segment will depict a 7.3% CAGR through 2032. The expanding need for biomarker research and personalized medicine will drive growth in the segment. The accelerating demand for well-preserved human tissue samples to advance medical research and develop targeted treatments will also foster growth across this segment.

The clinical research application segment will reflect 7.5% CAGR through 2032, driven by the increasing demand for well-documented samples to advance drug discovery and precision medicine. Collaborations between biobanks and research institutions and the expansion of clinical trials will further augment growth in the segment.

Regionally, the Asia Pacific biobanking market will grow at 7.5% CAGR during the analysis period. Rising research activities, especially in genomics and personalized medicine, will drive the demand for biorepositories in the region. In addition, increasing collaborations with international research institutions and the growing awareness of the importance of biobanking for medical research will also influence regional industry dynamics.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market definition
• 1.2 Base estimates & calculations
• 1.3 Forecast calculation
• 1.4 Covid-19 impact analysis at global level
• 1.5 Data validation
• 1.6 Data sources
  • 1.6.1 Secondary
    • 1.6.1.1 Paid sources
    • 1.6.1.2 Public sources
  • 1.6.2 Primary

Chapter 2 Executive Summary

• 2.1 Biobanking industry 360 degree synopsis, 2018 - 2032 (USD Million)
  • 2.1.1 Business trends
  • 2.1.2 Regional trends
  • 2.1.3 Product and service trends
  • 2.1.4 Sample type trends
  • 2.1.5 Application trends
  • 2.1.6 Storage type trends
  • 2.1.7 End-user trends

Chapter 3 Biobanking Market Insights

• 3.1 Industry landscape, 2018 - 2032 (USD Million)
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Technological advancements in genomics, personalized medicine, and drug development
    • 3.2.1.2 Increasing demand for personalized medicine
    • 3.2.1.3 Increasing investments in genomic research
    • 3.2.1.4 Integration of bioinformatics tools and advanced data analysis techniques
    • 3.2.1.5 Increased need for cost-effective drug discovery and development
    • 3.2.1.6 Growing investments and fundings for biobanks
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost associated with automated systems
    • 3.2.2.2 Issues related to biospecimen sample procurement
    • 3.2.2.3 Data privacy and ethical concerns
    • 3.2.2.4 High cost required for establishing and maintaining biobanks
    • 3.2.2.5 Lack of incompatibility between different biobank data systems
• 3.3 Growth potential analysis
  • 3.3.1 By product and service
  • 3.3.2 By sample type
  • 3.3.3 By application
  • 3.3.4 By storage type
  • 3.3.5 By end-user
• 3.4 COVID-19 impact analysis
• 3.5 Regulatory landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Global company market share analysis, 2022
• 4.4 Competitive positioning matrix, 2022
• 4.5 Strategic dashboard, 2022

Chapter 5 Biobanking Market, By Product and Service, 2018 - 2032 (USD Million)

• 5.1 Key trends, by products and service
• 5.2 Equipment
  • 5.2.1 Storage equipment
  • 5.2.2 Sample analysis equipment
  • 5.2.3 Sample processing equipment
  • 5.2.4 Sample transport equipment
• 5.3 Consumable
  • 5.3.1 Storage consumables
  • 5.3.2 Analysis consumables
  • 5.3.3 Processing consumables
  • 5.3.4 Collection consumables
• 5.4 Service
  • 5.4.1 Storage services
  • 5.4.2 Processing services
  • 5.4.3 Transport services
  • 5.4.4 Supply services
• 5.5 Software

Chapter 6 Biobanking Market, By Sample Type, 2018 - 2032 (USD Million)

• 6.1 Key trends, by sample type
• 6.2 Blood products
• 6.3 Human tissues
• 6.4 Cell lines
• 6.5 Nucleic acids
• 6.6 Biological fluids
• 6.7 Human waste products

Chapter 7 Biobanking Market, By Application, 2018 - 2032 (USD Million)

• 7.1 Key trends, by application
• 7.2 Regenerative medicine
• 7.3 Life-science research
• 7.4 Clinical research

Chapter 8 Biobanking Market, By Storage Type, 2018 - 2032 (USD Million)

• 8.1 Key trends, by storage type
• 8.2 Automated storage
• 8.3 Manual storage

Chapter 9 Biobanking Market, By End-user, 2018 - 2032 (USD Million)

• 9.1 Key trends, by end-user
• 9.2 Biotechnology & Pharmaceutical Companies
• 9.3 Contract research organizations (CROs)
• 9.4 Academic & Research Institutes
• 9.5 Hospitals

Chapter 10 Biobanking Market, By Region, 2018 - 2032 (USD Million)

• 10.1 Key trends, by region
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Spain
  • 10.3.5 Italy
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 Japan
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 Rest of Asia Pacific
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Rest of Latin America
• 10.6 Middle East & Africa
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 Rest of Middle East & Africa

Chapter 11 Company Profiles

• 11.1 Thermo Fisher Scientific, Inc.
• 11.2 PHC Holdings Corporation
• 11.3 Hamilton Company
• 11.4 Avantor Inc.
• 11.5 Qiagen N.V.
• 11.6 Tecan Trading AG
• 11.7 Merck & Co., Inc.
• 11.8 Becton, Dickinson and Company
• 11.9 Cryoport Inc.
• 11.10 Azenta Inc.